{
  "main_header": {
    "sid": 479596,
    "name": "Brawn Biotech",
    "stock_name": "Brawn Biotech",
    "full_name": "Brawn Biotech Ltd",
    "name_url": "stocks-analysis/brawn-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "16.00",
    "chg": -0.7,
    "chgp": "-4.19%",
    "dir": -1,
    "prev_price": "16.70",
    "mcapval": "4.80 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530207,
    "symbol": "",
    "ind_name": "Trading",
    "ind_code": 49,
    "isin": "INE899B01015",
    "curr_date": "Apr 11, 12:50 PM",
    "curr_time": "00:12 AM",
    "bse_nse_vol": "1.05 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/brawn-biotech-479596-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Brawn Biotech Ltd Sees Strong Buying Activity Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-ltd-rises-3-05-today-marking-8-19-gain-over-last-two-days-1697720",
        "imagepath": "",
        "date": "2025-04-03 12:40:09",
        "description": "Brawn Biotech Ltd is currently witnessing significant buying activity, with the stock gaining 3.05% today, contrasting sharply with the Sensex, which has declined by 0.34%. Over the past week, Brawn Biotech has shown a robust performance, increasing by 6.16%, while the Sensex has dropped by 1.61%. Notably, the stock has experienced consecutive gains over the last two days, accumulating a total return of 8.19%.\n\nDespite this recent uptick, Brawn Biotech's longer-term performance reveals challenges, with a decline of 14.21% over the past month and a notable 26.49% drop over the last three months. Year-to-date, the stock is down 17.55%, while the Sensex has only decreased by 2.28%. \n\nToday's trading session opened with a gap up, indicating strong buyer interest, and the stock's intraday performance reflects a positive trend relative to its sector. However, it remains below its 20-day, 50-day, 100-day, and 200-..."
      },
      {
        "title": "Brawn Biotech Ltd Sees Notable Price Recovery Amidst Recent Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-ltd-surges-4-99-today-defying-broader-market-trends-amid-recent-declines-1674642",
        "imagepath": "",
        "date": "2025-04-02 11:25:10",
        "description": "Brawn Biotech Ltd is witnessing significant buying activity today, with the stock rising by 4.99%, notably outperforming the Sensex, which has gained only 0.61%. This uptick comes after three consecutive days of declines, indicating a potential trend reversal. Despite this daily gain, Brawn Biotech's performance over the past week shows a decline of 2.01%, while the Sensex fell by 1.03%.\n\nIn terms of longer-term performance, Brawn Biotech has faced challenges, with a 16.75% drop over the past month and a 27.32% decline over the last three months. Year-to-date, the stock is down 19.99%, contrasting sharply with the Sensex's modest decline of 2.11%. Over the past five years, Brawn Biotech has seen a decrease of 8.58%, while the Sensex has surged by 170.61%.\n\nToday's trading session opened with a gap up, and the stock's intraday performance reflects a recovery from recent lows. The stock is currently trading a..."
      },
      {
        "title": "Brawn Biotech Ltd Sees Increased Buying Activity Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-ltd-faces-3-32-decline-trading-near-52-week-low-amid-ongoing-selling-pressure-1642937",
        "imagepath": "",
        "date": "2025-03-28 12:35:06",
        "description": "Brawn Biotech Ltd is currently witnessing significant buying activity, despite its recent performance trends indicating a downward trajectory. The stock has experienced consecutive losses over the past two days, with a decline of 8.05%. Today, it closed down by 3.32%, underperforming the Sensex, which fell by only 0.42%. \n\nOver the past week, Brawn Biotech has decreased by 1.17%, while the Sensex has gained 0.49%. The stock's performance over the last month shows a notable decline of 21.88%, contrasting sharply with the Sensex's increase of 5.58%. Year-to-date, Brawn Biotech is down 24.92%, compared to the Sensex's modest decline of 1.09%. \n\nThe stock is currently trading close to its 52-week low, just 3.37% away from Rs 15.46. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The buying pressure may be attributed to market participants loo..."
      },
      {
        "title": "Brawn Biotech Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-ltd-faces-heavy-selling-pressure-declines-4-94-amid-ongoing-losses-2-1625551",
        "imagepath": "",
        "date": "2025-03-27 12:35:07",
        "description": "Brawn Biotech Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, marking a notable trend reversal after two days of gains. Today, Brawn Biotech's performance declined by 4.94%, starkly contrasting with the Sensex, which gained 0.38%. Over the past week, the stock has lost 2.65%, while the Sensex rose by 1.62%. \n\nIn a broader context, Brawn Biotech's performance over the past month reveals a substantial decline of 19.24%, compared to a 3.99% increase in the Sensex. The stock has underperformed the sector by 5.66% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. \n\nOver the past year, Brawn Biotech has seen a decline of 13.18%, while the Sensex has appreciated by 6.29%. The year-to-date performance also reflects a drop of 22.38% against a s..."
      },
      {
        "title": "Brawn Biotech Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-ltd-faces-significant-selling-pressure-with-16-75-monthly-loss-amid-market-gains-1609479",
        "imagepath": "",
        "date": "2025-03-26 15:35:06",
        "description": "Brawn Biotech Ltd is currently facing significant selling pressure, with today's trading session showing only sellers in the market. The stock has experienced consecutive days of losses, reflecting a broader trend of declining performance. Over the past month, Brawn Biotech has dropped by 16.75%, while the Sensex has gained 3.60%, highlighting a stark contrast in performance.\n\nIn the short term, Brawn Biotech's one-day performance shows a decline of 3.57%, even as the Sensex fell by only 0.93%. This trend continues over the week, with the stock down 0.57% compared to the Sensex's increase of 2.44%. Over the last three months, Brawn Biotech has lost 27.53%, while the Sensex has seen a modest decline of 1.51%. \n\nSeveral factors may be contributing to this selling pressure, including market sentiment and potential concerns regarding the company's financial health. The stock's performance relative to key moving..."
      },
      {
        "title": "Brawn Biotech Ltd Experiences Notable Buying Surge Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-ltd-surges-4-17-today-achieving-9-38-gains-over-two-days-amid-market-decline-1606263",
        "imagepath": "",
        "date": "2025-03-26 13:35:06",
        "description": "Brawn Biotech Ltd is currently witnessing significant buying activity, with the stock rising by 4.17% today, contrasting sharply with the Sensex, which has declined by 0.65%. This marks the second consecutive day of gains for Brawn Biotech, accumulating a total return of 9.38% over this period. \n\nDespite this recent uptick, the stock has faced challenges over the longer term, with a 1-month decline of 16.27% and a 3-month drop of 27.11%. Year-to-date, Brawn Biotech is down 17.88%, while its performance over the past year shows a decrease of 3.58%. In comparison, the Sensex has shown a positive return of 6.95% over the same timeframe.\n\nToday's trading session opened with a gap up, indicating strong initial buyer interest. The stock's intraday performance suggests it is currently above its 5-day moving average but remains below its 20-day, 50-day, 100-day, and 200-day moving averages. This divergence may indi..."
      },
      {
        "title": "Brawn Biotech Ltd Sees Notable Price Increase Amid Ongoing Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-ltd-surges-5-00-today-reversing-three-day-decline-amid-broader-market-gains-1579174",
        "imagepath": "",
        "date": "2025-03-25 10:35:13",
        "description": "Brawn Biotech Ltd is currently witnessing significant buying activity, with a notable 5.00% increase in its stock price today, outperforming the Sensex, which rose by 0.56%. This marks a trend reversal for Brawn Biotech, as the stock has gained after three consecutive days of decline. Despite this positive movement, the stock's performance over the past week shows a decrease of 1.75%, while it has faced larger declines of 19.62% over the past month and 32.29% over the last three months.\n\nIn terms of price summary, Brawn Biotech opened with a gap up today, indicating strong initial buyer interest. However, it is important to note that the stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a longer-term bearish trend. \n\nThe buying pressure may be attributed to various factors, including market sentiment and potential developments within the trading ind..."
      },
      {
        "title": "Brawn Biotech Faces Continued Volatility Amid Operational Challenges and Poor Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-hits-52-week-low-amid-ongoing-decline-and-weak-financials-1574147",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/BrawnBiotech_priceRelatedfactors_771643.png",
        "date": "2025-03-24 10:36:12",
        "description": "Brawn Biotech has faced significant volatility, reaching a new 52-week low and underperforming its sector. The company has struggled with operational challenges, including substantial losses and declining sales growth. Its technical indicators reflect a bearish trend, contributing to a challenging overall outlook despite some recent positive results."
      },
      {
        "title": "Brawn Biotech Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brawn-biotech-ltd-faces-significant-selling-pressure-with-4-91-decline-amid-ongoing-losses-1501997",
        "imagepath": "",
        "date": "2025-03-20 11:35:09",
        "description": "Brawn Biotech Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, with a notable decline of 4.91% in its one-day performance. This starkly contrasts with the Sensex, which has gained 0.61% during the same period. Over the past week, Brawn Biotech has dropped 3.42%, while the Sensex has risen by 2.81%. \n\nIn the last month, the stock has plummeted by 20.76%, compared to a modest 0.22% increase in the Sensex. The three-month performance shows a decline of 27.34% for Brawn Biotech, while the Sensex has only decreased by 2.74%. Year-to-date, the stock is down 21.91%, against a 2.86% decline in the Sensex. \n\nBrawn Biotech's performance has consistently underperformed relative to the broader market, with the stock trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The trading sector over..."
      }
    ],
    "total": 24,
    "sid": "479596",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/brawn-biotech-479596"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "28-Mar-2025",
      "details": "Closure of Trading window for Designated Persons and their immediate relatives with effect from 1st April 2025.",
      "source": "BSE"
    },
    {
      "caption": "Integrated Filing (Financial)",
      "datetime": "14-Feb-2025",
      "details": "UFR in integrated filing is attached.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Feb-2025",
      "details": "Intimation of publication of unaudited financial results under regulation 47.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Brawn Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 12 Sep 18",
          "dt": "2018-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Brawn Biotech Ltd Sees Strong Buying Activity Amid Broader Market Decline

2025-04-03 12:40:09

Brawn Biotech Ltd is currently witnessing significant buying activity, with the stock gaining 3.05% today, contrasting sharply with the Sensex, which has declined by 0.34%. Over the past week, Brawn Biotech has shown a robust performance, increasing by 6.16%, while the Sensex has dropped by 1.61%. Notably, the stock has experienced consecutive gains over the last two days, accumulating a total return of 8.19%. Despite this recent uptick, Brawn Biotech's longer-term performance reveals challenges, with a decline of 14.21% over the past month and a notable 26.49% drop over the last three months. Year-to-date, the stock is down 17.55%, while the Sensex has only decreased by 2.28%. Today's trading session opened with a gap up, indicating strong buyer interest, and the stock's intraday performance reflects a positive trend relative to its sector. However, it remains below its 20-day, 50-day, 100-day, and 200-...

Read More

Brawn Biotech Ltd Sees Notable Price Recovery Amidst Recent Declines

2025-04-02 11:25:10

Brawn Biotech Ltd is witnessing significant buying activity today, with the stock rising by 4.99%, notably outperforming the Sensex, which has gained only 0.61%. This uptick comes after three consecutive days of declines, indicating a potential trend reversal. Despite this daily gain, Brawn Biotech's performance over the past week shows a decline of 2.01%, while the Sensex fell by 1.03%. In terms of longer-term performance, Brawn Biotech has faced challenges, with a 16.75% drop over the past month and a 27.32% decline over the last three months. Year-to-date, the stock is down 19.99%, contrasting sharply with the Sensex's modest decline of 2.11%. Over the past five years, Brawn Biotech has seen a decrease of 8.58%, while the Sensex has surged by 170.61%. Today's trading session opened with a gap up, and the stock's intraday performance reflects a recovery from recent lows. The stock is currently trading a...

Read More

Brawn Biotech Ltd Sees Increased Buying Activity Amid Significant Price Declines

2025-03-28 12:35:06

Brawn Biotech Ltd is currently witnessing significant buying activity, despite its recent performance trends indicating a downward trajectory. The stock has experienced consecutive losses over the past two days, with a decline of 8.05%. Today, it closed down by 3.32%, underperforming the Sensex, which fell by only 0.42%. Over the past week, Brawn Biotech has decreased by 1.17%, while the Sensex has gained 0.49%. The stock's performance over the last month shows a notable decline of 21.88%, contrasting sharply with the Sensex's increase of 5.58%. Year-to-date, Brawn Biotech is down 24.92%, compared to the Sensex's modest decline of 1.09%. The stock is currently trading close to its 52-week low, just 3.37% away from Rs 15.46. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The buying pressure may be attributed to market participants loo...

Read More

Brawn Biotech Faces Intense Selling Pressure Amid Significant Price Declines

2025-03-27 12:35:07

Brawn Biotech Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, marking a notable trend reversal after two days of gains. Today, Brawn Biotech's performance declined by 4.94%, starkly contrasting with the Sensex, which gained 0.38%. Over the past week, the stock has lost 2.65%, while the Sensex rose by 1.62%. In a broader context, Brawn Biotech's performance over the past month reveals a substantial decline of 19.24%, compared to a 3.99% increase in the Sensex. The stock has underperformed the sector by 5.66% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past year, Brawn Biotech has seen a decline of 13.18%, while the Sensex has appreciated by 6.29%. The year-to-date performance also reflects a drop of 22.38% against a s...

Read More

Brawn Biotech Faces Intense Selling Pressure Amid Significant Price Declines

2025-03-26 15:35:06

Brawn Biotech Ltd is currently facing significant selling pressure, with today's trading session showing only sellers in the market. The stock has experienced consecutive days of losses, reflecting a broader trend of declining performance. Over the past month, Brawn Biotech has dropped by 16.75%, while the Sensex has gained 3.60%, highlighting a stark contrast in performance. In the short term, Brawn Biotech's one-day performance shows a decline of 3.57%, even as the Sensex fell by only 0.93%. This trend continues over the week, with the stock down 0.57% compared to the Sensex's increase of 2.44%. Over the last three months, Brawn Biotech has lost 27.53%, while the Sensex has seen a modest decline of 1.51%. Several factors may be contributing to this selling pressure, including market sentiment and potential concerns regarding the company's financial health. The stock's performance relative to key moving...

Read More

Brawn Biotech Ltd Experiences Notable Buying Surge Amid Broader Market Decline

2025-03-26 13:35:06

Brawn Biotech Ltd is currently witnessing significant buying activity, with the stock rising by 4.17% today, contrasting sharply with the Sensex, which has declined by 0.65%. This marks the second consecutive day of gains for Brawn Biotech, accumulating a total return of 9.38% over this period. Despite this recent uptick, the stock has faced challenges over the longer term, with a 1-month decline of 16.27% and a 3-month drop of 27.11%. Year-to-date, Brawn Biotech is down 17.88%, while its performance over the past year shows a decrease of 3.58%. In comparison, the Sensex has shown a positive return of 6.95% over the same timeframe. Today's trading session opened with a gap up, indicating strong initial buyer interest. The stock's intraday performance suggests it is currently above its 5-day moving average but remains below its 20-day, 50-day, 100-day, and 200-day moving averages. This divergence may indi...

Read More

Brawn Biotech Ltd Sees Notable Price Increase Amid Ongoing Market Challenges

2025-03-25 10:35:13

Brawn Biotech Ltd is currently witnessing significant buying activity, with a notable 5.00% increase in its stock price today, outperforming the Sensex, which rose by 0.56%. This marks a trend reversal for Brawn Biotech, as the stock has gained after three consecutive days of decline. Despite this positive movement, the stock's performance over the past week shows a decrease of 1.75%, while it has faced larger declines of 19.62% over the past month and 32.29% over the last three months. In terms of price summary, Brawn Biotech opened with a gap up today, indicating strong initial buyer interest. However, it is important to note that the stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a longer-term bearish trend. The buying pressure may be attributed to various factors, including market sentiment and potential developments within the trading ind...

Read More

Brawn Biotech Faces Continued Volatility Amid Operational Challenges and Poor Performance

2025-03-24 10:36:12

Brawn Biotech has faced significant volatility, reaching a new 52-week low and underperforming its sector. The company has struggled with operational challenges, including substantial losses and declining sales growth. Its technical indicators reflect a bearish trend, contributing to a challenging overall outlook despite some recent positive results.

Read More

Brawn Biotech Faces Intense Selling Pressure Amid Significant Price Declines

2025-03-20 11:35:09

Brawn Biotech Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, with a notable decline of 4.91% in its one-day performance. This starkly contrasts with the Sensex, which has gained 0.61% during the same period. Over the past week, Brawn Biotech has dropped 3.42%, while the Sensex has risen by 2.81%. In the last month, the stock has plummeted by 20.76%, compared to a modest 0.22% increase in the Sensex. The three-month performance shows a decline of 27.34% for Brawn Biotech, while the Sensex has only decreased by 2.74%. Year-to-date, the stock is down 21.91%, against a 2.86% decline in the Sensex. Brawn Biotech's performance has consistently underperformed relative to the broader market, with the stock trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The trading sector over...

Read More

View All News